Determinants of influenza vaccine uptake and willingness to be vaccinated by pharmacists among the active adult population in Hungary: a cross-sectional exploratory study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
    • Abstract:
      Background: Many studies have addressed influenza vaccine uptake in risk-group populations (e.g. the elderly). However, it is also necessary to assess influenza vaccine uptake in the active adult population, since they are considered to be a high-transmitter group. In several countries pharmacists are involved in adult vaccination in order to increase uptake. This study therefore aimed to investigate the determinants of influenza vaccination uptake and examine the willingness to be vaccinated by pharmacists.
      Methods: A cross-sectional study was conducted among Hungarian adults using a self-administered online questionnaire distributed via social media (Facebook). The questionnaire included five domains: demographics, vaccine uptake, factors that motivated or discouraged vaccination, knowledge and willingness of participants to accept pharmacists as influenza vaccine administrators. Descriptive statistics were applied and logistic regression was conducted to assess the possible determinants of vaccination uptake.
      Results: Data from 1631 participants who completed the questionnaires were analysed. Almost 58% of respondents (944/1631) had occupational and/or health risk factors for influenza. Just over one-tenth (12.3%;200/1631) of participants were vaccinated during the 2017/18 influenza season, 15.4% (145/944) of whom had a risk factor for influenza. Approximately half of the participants (47.4%) believed that influenza vaccination can cause flu, and just over half of them (51.6%), were not knowledgeable about the safety of influenza vaccine ingredients. Logistic regression found that age, sex, health risk factor and knowledge on influenza/influenza vaccination were associated with influenza vaccination uptake (p < 0.05). The most frequently cited reason for having an influenza vaccination was self-protection (95.0%). The most common reason given for refusing the influenza vaccine was that the respondent stated they rarely had an infectious disease (67.7%). The number of participants who were willing to be vaccinated by pharmacists was two-times higher than the number of participants who were actually vaccinated during the 2017/18 influenza season.
      Conclusion: Influenza vaccine uptake in the active adult population is low in Hungary. Public awareness and knowledge about influenza vaccination and influenza disease should be increased. The results also suggest a need to extend the role played by pharmacists in Hungary.
    • References:
      Int J Clin Pharm. 2018 Dec;40(6):1519-1527. (PMID: 30367377)
      Vaccine. 2018 May 31;36(23):3231-3238. (PMID: 29716775)
      Ann Pharm Fr. 2017 Jan;75(1):3-8. (PMID: 27717412)
      Can Pharm J (Ott). 2015 Mar;148(2):64-7. (PMID: 25918537)
      Vaccine. 2018 Jun 14;36(25):3606-3612. (PMID: 29773322)
      BMC Public Health. 2015 Jul 07;15:618. (PMID: 26148480)
      Vaccine. 2014 Aug 6;32(36):4602-13. (PMID: 24996123)
      Vaccine. 2014 Apr 17;32(19):2150-9. (PMID: 24598724)
      J Public Health (Oxf). 2016 Dec 02;38(4):746-753. (PMID: 28158550)
      BMC Public Health. 2013 Dec 21;13:1221. (PMID: 24359091)
      Science. 2009 Sep 25;325(5948):1705-8. (PMID: 19696313)
      Vaccine. 2016 Nov 11;34(47):5708-5723. (PMID: 27765379)
      Vaccine. 2016 Nov 11;34(47):5808-5814. (PMID: 27707558)
      Prev Med. 2016 Mar;84:57-61. (PMID: 26757401)
      Euro Surveill. 2018 Apr;23(16):. (PMID: 29692315)
      Hum Vaccin Immunother. 2018 Mar 4;14(3):693-698. (PMID: 28922083)
      Vaccine. 2009 Jun 19;27(30):4018-24. (PMID: 19389442)
      BMC Public Health. 2016 Feb 04;16:121. (PMID: 26846202)
      Am J Infect Control. 2017 Jul 1;45(7):740-745. (PMID: 28449918)
      Math Biosci Eng. 2011 Jan;8(1):123-39. (PMID: 21361404)
      BMC Infect Dis. 2016 Sep 26;16(1):515. (PMID: 27670446)
      Hum Vaccin Immunother. 2018 Mar 4;14(3):706-711. (PMID: 29303681)
      J Hosp Infect. 2017 Jul;96(3):268-275. (PMID: 28283372)
      Int J Clin Pharm. 2016 Apr;38(2):218-22. (PMID: 26821372)
      Hum Vaccin Immunother. 2017 Jan 2;13(1):103-110. (PMID: 27690757)
      Vaccine. 2018 Nov 26;36(49):7556-7561. (PMID: 30389192)
      BMC Health Serv Res. 2017 Nov 15;17(1):732. (PMID: 29141619)
      BMC Public Health. 2015 Sep 29;15:981. (PMID: 26416304)
      BMC Public Health. 2015 May 16;15:493. (PMID: 25981624)
      PLoS One. 2017 Jan 26;12(1):e0170550. (PMID: 28125629)
      BMJ Open. 2016 Feb 16;6(2):e009739. (PMID: 26883237)
      Immunology. 2007 Apr;120(4):435-46. (PMID: 17313487)
      J Infect Public Health. 2017 Nov - Dec;10(6):897-900. (PMID: 28473261)
    • Grant Information:
      4597 University of Szeged Open Access Fund
    • Contributed Indexing:
      Keywords: Adult; Determinants; Influenza vaccine; Pharmacists; Vaccine uptake
    • Accession Number:
      0 (Influenza Vaccines)
    • Publication Date:
      Date Created: 20210318 Date Completed: 20210521 Latest Revision: 20210521
    • Publication Date:
      20240105
    • Accession Number:
      PMC7967972
    • Accession Number:
      10.1186/s12889-021-10572-8
    • Accession Number:
      33731073